Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. SC 13G/A Stake Amended Statement of Ownership
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-3/A Offering Registration Statement
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. EFFECT Other Notice of Effectiveness
  14. 4 Derivatives Options or other derivatives
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Shareholder vote results
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 25 of 37 · 725 filings